Oxybutynin and cognitive dysfunction.
Donnellan
C A
CA
Department of Geriatric Medicine, Royal Liverpool University Hospital.
Fook
L
L
McDonald
P
P
Playfer
J R
JR
D000368:Aged; D000369:Aged, 80 and over; D018680:Cholinergic Antagonists / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000139:chemically induced*; D003221:Confusion / Q000139:chemically induced; D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000009:adverse effects*; D010300:Parkinson Disease / Q000188:drug therapy
D018680:Cholinergic Antagonists; D008333:Mandelic Acids; C005419:oxybutynin